Dr. Bret E. Friday
Claim this profileEssentia Health Cancer Center
Expert in Skin Cancer
Expert in Cancer
118 reported clinical trials
189 drugs studied
About Bret E. Friday
Education:
- Graduated with an MD from the University of Minnesota Medical School, Twin Cities Campus, in 2007.
- Completed Residency in Radiation Oncology at the University of Minnesota Medical Center in 2012.
- Undertook a Fellowship in Brachytherapy at the University of Minnesota Medical Center in 2013.
Experience:
- Board Certified in Radiation Oncology by the American Board of Radiology.
- Has been practicing as a Radiation Oncologist at Essentia Health Cancer Center since 2013.
Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage I
2Cancer
Global LeaderStage IV
KRAS positive
Stage III
Affiliated Hospitals
Clinical Trials Bret E. Friday is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Bret E. Friday
Clinical Trial Related5 years of experience running clinical trials · Led 118 trials as a Principal Investigator · 65 Active Clinical TrialsTreatments Bret E. Friday has experience with
- Nivolumab
- Pembrolizumab
- Paclitaxel
- Fluorouracil
- Carboplatin
- Ipilimumab
Breakdown of trials Bret E. Friday has run
Skin Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bret E. Friday specialize in?
Bret E. Friday focuses on Skin Cancer and Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Bret E. Friday currently recruiting for clinical trials?
Yes, Bret E. Friday is currently recruiting for 62 clinical trials in Duluth Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Bret E. Friday has studied deeply?
Yes, Bret E. Friday has studied treatments such as Nivolumab, Pembrolizumab, Paclitaxel.
What is the best way to schedule an appointment with Bret E. Friday?
Apply for one of the trials that Bret E. Friday is conducting.
What is the office address of Bret E. Friday?
The office of Bret E. Friday is located at: Essentia Health Cancer Center, Duluth, Minnesota 55805 United States. This is the address for their practice at the Essentia Health Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.